Unknown

Dataset Information

0

Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell Carcinoma.


ABSTRACT: INTRODUCTION:Immune checkpoint inhibitors (ICI) have been approved for patients with clear cell renal cell carcinoma (ccRCC), but not all patients benefit from ICI. One reason is the tumor microenvironment (TME) that has substantial influence on patient's prognosis and therapy response. Thus, we comprehensively analyzed the TME of ccRCC regarding prognostic and predictive properties. METHODS:Tumor-infiltrating CD3-positive T-cells, CD8-positive cytotoxic T-lymphocytes (CTLs), regulatory T-cells, B-cells, plasma cells, macrophages, granulocytes, programmed cell death receptor 1 (PD-1), and its ligand PD-L1 were examined in a large hospital-based series of ccRCC with long-term follow-up information (n = 756) and in another patient collective with information on response to nivolumab therapy (n = 8). Tissue microarray technique and digital image analysis were used. Relationship between immune cell infiltration and tumor characteristics, cancer-specific survival (CSS), or response to ICI was examined. RESULTS:Univariate survival analysis revealed that increased tumor-infiltrating B-cells, T-cells, and PD-1-positive cells were significantly associated with favorable CSS and high levels of intratumoral granulocytes, macrophages, cytotoxic T-cells, and PD-L1 significantly with poor CSS. High CTL or B-cell infiltration and high PD-L1 expression of ccRCC tumor cells qualified as independent prognostic biomarkers for patients' CSS. Significantly higher densities of intratumoral T-cells, CTLs, and PD-1-positive immune cells were observed in ccRCC with response to ICI compared with patients with mixed or no response (CD3: p = 0.003; CD8: p = 0.006; PD-1: p = 0.01). DISCUSSION:This study shows that subsets of tumor-infiltrating leukocytes in the TME and also PD-1/PD-L1 provide prognostic and predictive information for patients with ccRCC.

SUBMITTER: Stenzel PJ 

PROVIDER: S-EPMC7031108 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2021-01-01 | S-EPMC7909271 | BioStudies
1000-01-01 | S-EPMC5504334 | BioStudies
2020-01-01 | S-EPMC7568713 | BioStudies
2020-01-01 | S-EPMC7027009 | BioStudies
2015-01-01 | S-EPMC4596765 | BioStudies
2019-01-01 | S-EPMC6880569 | BioStudies
2018-01-01 | S-EPMC6141531 | BioStudies
2017-01-01 | S-EPMC5731248 | BioStudies
2019-01-01 | S-EPMC6572544 | BioStudies
2012-07-09 | E-GEOD-39205 | ArrayExpress